Please assess the completion status of the following clinical trial:

Trial Title: Altered PSA Test Due to Possible Suspected Heterophilic Antibodies

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male, with a a clinically high or low unexplainable PSA measurement~* Age between 40 and 90 years~* Written informed consent~Exclusion Criteria:~* Female~* No PSA measurement available or planned~* Age over 90 or under 40 years

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).